Emerald Health Therapeutics, Inc. (CVE:EMH – Get Free Report) shares dropped 3.8% on Thursday . The company traded as low as C$0.25 and last traded at C$0.26. Approximately 384,329 shares changed hands during trading, a decline of 40% from the average daily volume of 644,760 shares. The stock had previously closed at C$0.27.
Emerald Health Therapeutics Stock Performance
The firm has a market capitalization of C$52.28 million and a price-to-earnings ratio of -0.37. The company has a debt-to-equity ratio of 35.45, a quick ratio of 2.61 and a current ratio of 2.97. The stock’s fifty day moving average is C$0.26 and its two-hundred day moving average is C$0.26.
About Emerald Health Therapeutics
Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015.
Read More
- Five stocks we like better than Emerald Health Therapeutics
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Why Palo Alto Networks’ Multi-Year Uptrend Is Far From Over
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- 3 Rock-Solid Buying Opportunities in the Market Right Now
- What Are Dividend Champions? How to Invest in the Champions
- TJX Companies Stock Poised to Hit a New High This Year
Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
